03/04
Headlines

Finance

Hot Biotech Movers: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Insmed Incorporated (NASDAQ:INSM), Gilead Sciences, Inc. (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Kristen Barton03 mins

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) saw a significant decrease in short interest during the month of May. As of May 30th, there was short interest totalling 8,284,614 shares, a decrease of 15.5% from the May 15th total of 9,799,100 shares. Several analysts have recently commented on the stock. Analysts at Roth Capital downgraded shares of…

Read More

NASDAQ Insider Selling: Cisco Systems, Inc. (NASDAQ:CSCO), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), NVIDIA Corporation (NASDAQ:NVDA), Autodesk, Inc. (NASDAQ:ADSK), FireEye Inc (NASDAQ:FEYE)

Jayne Crisman03 mins

Cisco Systems Inc (NASDAQ:CSCO) EVP Pankaj Patel unloaded 90,000 shares of the company’s stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $24.59, for a total value of $2,213,100.00. Following the completion of the transaction, the executive vice president now directly owns 582,497 shares of…

Read More

Healthcare Stocks In News: Ultragenyx (NASDAQ:RARE), Flexion (NASDAQ:FLXN), Receptos Inc (NASDAQ:RCPT), Acorda Therapeutics (NASDAQ:ACOR), Aratana Therapeutics (NASDAQ:PETX)

Mark DeFrance03 mins

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) is up over 16% today on news of the company’s initiation of phase-II trials for its lead drug candidate KRN23, which is a monoclonal antibody for X-linked Hypophosphatemia (XLH). Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) stock performance was 14.30% in last session and finished the day at $48.67. Traded volume was 435,645.00million shares…

Read More

Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)

Jayne Crisman03 mins

Aldeyra Therapeutics Inc (NASDAQ:ALDX) quiet period is set to expire on Wednesday, June 11th. Aldeyra Therapeutics had issued 1,500,000 shares in its IPO on May 2nd, AR Network reports. The total size of the offering was $12,000,000 based on an initial share price of $8.00. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -7.08% in last…

Read More

NASDAQ Insider Buying: Prospect Capital (NASDAQ:PSEC), CyrusOne (NASDAQ:CONE), National Penn Bancshares (NASDAQ:NPBC), Insys Therapeutics (NASDAQ:INSY), Bank Of The Ozarks (NASDAQ:OZRK)

Jayne Crisman03 mins

Prospect Capital Corp. (NASDAQ:PSEC) CEO John F. Barry purchased 100,000 shares of the stock in a transaction dated Friday, June 13th. The stock was purchased at an average cost of $10.37 per share, for a total transaction of $1,037,000.00. Following the completion of the purchase, the chief executive officeronline.wsj.comchief executive officer now directly owns 4,110,959…

Read More

Stocks In News: Hewlett-Packard Company (NYSE:HPQ), Oracle Corporation (NYSE:ORCL), Cisco Systems, Inc. (NASDAQ:CSCO), International Business Machines Corp. (NYSE:IBM), Lenovo Group Limited (ADR) (OTCMKTS:LNVGY)

John Bellich02 mins

Hewlett-Packard Company (NYSE:HPQ) has released its own OpenStack distribution, called Helion, and, like Red Hat, plans to offer deployment and hosted services around the cloud software. Both companies are also building partner networks that will use these OpenStack distributions in products and services for specific industries or geographical areas. Hewlett-Packard Company (NYSE:HPQ) stock performance was…

Read More